Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-14-042792

Chief Executive Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Carpenter George C IV Chief Executive Officer 2014-07-10 Grant or award +50,000 $0.25 $12,500 1,390,799 D: show line 1 in the form
Loading xslF345X03/v383808_4.xml…